Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MPAC

Model Performance Acquisition (MPAC) Stock Price, News & Analysis

About Model Performance Acquisition Stock (NASDAQ:MPAC)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$2.59
$8.44
52-Week Range
N/A
Volume
328,500 shs
Average Volume
73,071 shs
Market Capitalization
$48.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MPAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Model Performance Acquisition and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MPAC Stock News Headlines

Schroders Boosts Stake in Mpac Group PLC
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.tc pixel
AA Mission Acquisition Corp Class A Ordinary Shares
Roth CH Acquisition V Co
Information processing model
See More Headlines

MPAC Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Model Performance Acquisition investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), General Finance (GFN), Park City Group (PCYG), Arbutus Biopharma (ABUS), ARCA biopharma (ABIO) and Aurora Cannabis (ACBFF).

Company Calendar

Today
8/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:MPAC
CIK
1670349
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$870 thousand
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-3.12%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.17
Quick Ratio
0.17

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.28) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
6,100,000
Free Float
3,196,000
Market Cap
$48.74 million
Optionable
Not Optionable
Beta
0.25
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:MPAC) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners